New insect system for testing antibiotics

Journal of Parasitology

Volumn 93, Issue 6, 2007, Pages 1505-1511

  Johny, Shajahan ^a   Lange, Carlos E ^a,b   Solter, Leellen F ^a,c   Merisko, Amber ^a   Whitman, Douglas W ^a  

^a ILLINOIS STATE UNIVERSITY   (United States)

^b CENTRO DE ESTUDIOS PARASITOLÓGICOS Y DE VECTORES CEPAVE   (Argentina)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AMPICILLIN; ANTIBIOTIC AGENT; CHLORAMPHENICOL; FUMAGILLIN; GRISEOFULVIN; METRONIDAZOLE; QUININE; STREPTOMYCIN; SULFADIMETHOXINE; TETRACYCLINE; TIABENDAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; DISEASE RESISTANCE; GRASSHOPPER; NEW SPECIES; PATHOGEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BACTERIAL SPORE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG SCREENING; ENCEPHALITOZOON; GRASSHOPPER; INSECT; MALE; MICROSPORIDA; NONHUMAN; SCREENING TEST;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; COSTS AND COST ANALYSIS; CYCLOHEXANES; DRUG EVALUATION, PRECLINICAL; ENCEPHALITOZOON; FATTY ACIDS, UNSATURATED; GRASSHOPPERS; MALE; MODELS, ANIMAL; QUININE; SESQUITERPENES; THIABENDAZOLE;

ANIMALIA; ENCEPHALITOZOON; HEXAPODA; MICROSPORIDIA; ROMALEA MICROPTERA;

EID: 38849138675     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-1213.1     Document Type: Conference Paper

References (85)

1. AKOVA, M. 2006. Emerging problem pathogens: A review of resistance patterns over time. International Journal of Infectious Diseases 10: S3-S8.
2. AMES, E. R., J. M. CHENEY, AND R. RUBIN. 1963. The efficacy of thiabendazole and bephenium hydroxynaphthoate against Ostertagio ostertagi and Cooperia oncophora in experimentally infected calves. American Journal of Veterinary Research 24: 295-299.
3. ANIMAL WELFARE INFORMATION CENTER. 2007. Federal Register, vol. 55, no. 32, 15 February 1991, p. 6426-6505.
4. Final Rule: Animal Welfare; Standards; Part 3 Animal Welfare Act, http://www.nal.usda.gov/awic/legislat/usdaleg1.htm.
5. ARMSTRONG, E. 1976. Fumadil-B and Benomyl chemical control of Nosema kingi in Drosophila willistoni. Journal of Invertebrate Pathology 27: 363-366.
6. AWADZI, K., M. HERO, AND N. O. OPOKU. 1994. The chemotherapy of onchocerciasis XVII: A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics. Tropical Medicine and Parasitology 45: 203-208.
7. BAILEY, L. 1953. Effect of fumagillin upon Nosema apis (Zander). Nature 171: 212-213.
8. BEAUVAIS, B., C. SARFATI, S. CHALLIER, AND F. DEROUIN. 1994. In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi. Antimicrobial Agents and Chemotherapy 38: 2440-2448.
9. BECNEL, J. J., AND T. G. ANDREADIS. 1999. Microsporidia in insects. In The Microsporidia and microsporidiosis, M. Wittner, and L. M. Weiss (eds.). American Society for Microbiology Press, Washington, D.C., p. 447-501.
10. BLANSHARD, C., D. S. ELLIS, D. G, TOVEY, S. DOWELL, AND B. G. GAZZARD. 1992. Treatment of intestinal microsporidiosis with albendazole in patients with AIDS. AIDS 6: 311-313.
11. _, S. P. DOWELL, G. TOVEY, AND B. G. GAZZARD. 1993. Electron microscopic changes in Enterocytozoon bieneusi following treatment with albendazole. Journal of Clinical Pathology 46: 898-902.
12. BOOHENE, C. K., C. J. GEDEN, AND J. J. BECNEL. 2003. Evaluation of remediation methods for Nosema disease in Muscidifurax raptor (Hymenoptera: Pteromalidae). Environmental Entomology 32: 1146-1153.
13. BRASIL, P., F. C. SODRE, T. CUZZI-M AYA, M. C. GUTIERREZ, H. MATTOS, AND H. MOURA. 1996. Intestinal microsporidiosis in HIV-positive patients with chronic unexplained diarrhea in Rio de Janeiro, Brazil: Diagnosis, clinical presentation and follow-up. Revista do Instituto de Medicina Tropical de São Paulo 38: 97-102.
14. BROWN, H. D., A. R. MATZUK, I. R. LIVES, L. H. PETERSON, S. A. HARRIS, L. H. SARETT, J. R. EGERTON, J. J. YAKSTIS, W. C. CAMPBELL, AND A. C. CUCKLER. 1961. Antiparasitic drugs, IV.2-(4-thiazolyl)-benzimidazole, a new anthelmintic. Journal of the American Chemical Society 83: 1764-1765.
15. BRYAN, R. T., AND D. A. SCHWARTZ. 1999. Epidemiology of microsporidiosis. In The Microsporidia and microsporidiosis, M. Wittner, and L. M. Weiss (eds.). American Society for Microbiology Press, Washington, D.C., p. 502-516.
16. CANNING, E. U., AND W. S. HOLLISTER. 1991. In vitro and in vivo investigations of human microsporidia. Journal of Protozoology 38: 631-635.
17. CARLOYE, L., J. V. MADDOX, AND M. R. BERENBAUM. 1998. Influence of natural and synthetic compounds on the infectivity of a Vairi morpha (Microspora) sp. in Trichoplusia ni (Lepidoptera: Noctuidae) larvae. Environmental Entomology 27: 976-983.
18. CLOPTON, R. E., AND A. SMITH. 2002. Efficacy of oral sulfadimethoxine against two gregarine parasites, Protomagalhaensia granulose and Gegarina cubensis (Apicomplexa: Eugregarinida), infecting the Death's Head Cockroach, Blaberus discoidalis. Journal of Parasitology 88: 786-789.
19. CONTEAS, C. N., O. G. W. BERLIN, L. R. ASH, AND J. S. PRUTHI. 2000. Therapy for human gastrointestinal microssoridiosis. American Journal of Tropical Medicine and Hygiene 63: 121-127.
20. COSTA, S. F., AND L. M. WEISS. 2000. Drug treatment of microsporidiosis. Drug Resistance Updates 3: 384-399.
21. CUCKLER, A. C. 1961. Thiabendazole, a new broad spectrum anthelmintic. Journal of Parasitology 47: 36-37.
22. CURRY, A. 2004. Emerging human protozoan infections in the temperate European climate. Journal of Submicroscopic Cytology and Pathology 36: 105-119.
23. DEPLAZES, P., A. MATHIS, AND R. WEBER. 2000. Epidemiology and zoonotic aspects of microsporidia of mammals and birds. Contributions to Microbiology 6: 236-260.
24. DIDIER, E. S. 2005. Microsporidiosis: An emerging and opportunistic infection in humans and animals. Acta Tropica 94: 61-76.
25. _, L. BOWERS, M. E. STOVALL, D. KUEBLER, D. MITTLEIDER, P. J. BRINDLEY, AND P. J. DIDIER. 2005. Antimicrosporidial activity of (fluoro)quinolones in vitro and in vivo. Folia Parasitologica 52: 173-181.
26. _, J. A. MADDRY, P. J. BRINDLEY, M. E. STOVALL, L. C. BOWERS, AND P. J. DIDIER. 2005. Therapeutic strategies for human microsporidia infections. Expert Review of Anti-infective Therapy 3: 1-16.
27. _, M. E. STOVALL, L. C. GREEN, P. J. BRINDLEY, K. SESTAK, AND P. J. DIDIER. 2004. Epidemiology of microsporidiosis: Sources and modes of transmission. Veterinary Parasitology 126: 145-166.
28. _, AND L. M. WEISS. 2006. Microsporidiosis: Current status. Current Opinion in Infectious Diseases 19: 485-492.
29. DIDIER, P. J., J. N. PHILLIPS, D. J. KUEBLER, M. NASR, P. J. BRINDLEY, M. E. STOVALL, L. C. BOWERS, AND E. S. DIDIER. 2006. Antimicrosporidial activities of fumagillin, TNP-470, ovalicin, and ovalicin derivatives in vitro and in vivo. Antimicrobial Agents and Chemotherapy 50: 2146-2155.
30. DIESENHOUSE, M. C., L. A. WILSON, G. F. CORRENT, G. S. VISVESVARA, H. E. GROSSNIKLAUS, AND R. T. BRYAN. 1993. Treatment of microsporidial keratoconjunctivies with topical fumagillin. American Journal of Ophthalmology 115: 293-298.
31. DIETERICH, D. T., E. A. LEW, D. P. KOTLER, M. A. POLES, AND J. M. ORENSTEIN. 1994. Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS. Journal of Infectious Diseases 166: 178-183.
32. DORE, G. J., D. J. MARRIOTT, M. C. HING, J. L. HARKNESS, AND A. S. FIELD. 1995. Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: Response to therapy with albendazole. Clinical Infectious Diseases 21: 70-76.
33. DOW, G. S., A. J. O'HARA, S. C. NEWTON, J. A. REYNOLDSON, AND R. C. A. THOMPSON. 2000. Plasmodium berghei: The antimalarial activity of albendazole in rats is mediated via effects on the hematopoietic system. Experimental Parasitology 94: 259-263.
34. _, J. A. REYNOLDSON, AND R. C. A. THOMPSON. 1998. Plasmodium berghei: In vivo efficacy of albendazole in different rodent models. Experimental Parasitology 88: 154-156.
35. EEFTINCK SCHATTENKERK, J. K., T. VAN GOOL, R. J. VAN KETEL, J. F. BARTELSMAN, C. L. KUIKEN, W. J. TERPSTRA, AND P. REISS. 1991. Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals. Lancet 337: 895-898.
36. FLINT, H. M., J. EATON, AND W. KLASSEN. 1972. The use of Fumidil-B to reduce the microsporidian disease in colonies of the boll weevil. Annals of the Entomological Society of America 65: 942-945.
37. FRANSSEN, F. F. J., J. T. LUMEIJ, AND F. V. KNAPEN. 1995. Susceptibility of Encephalitozoon cuniculi to several drugs in vitro. Antimicrobial Agents and Chemotherapy 39: 1265-1268.
38. GAUGHAN, D. J. 2002. Disease-translocation across geographic boundaries must be recognized as a risk even in the absence of disease identification: The case with Australian Sardinops. Reviews in Fish Biology and Fisheries 11: 113-123.
39. GOODWIN, R. H. 1984. Recognition and diagnosis of diseases in insectaries and the effects of disease agents on insect biology. In Advances and challenges in insect rearing, E. G. King and N. C. Leppla (eds.). U.S. Department of Agriculture, Agricultural Research Service, New Orleans, Louisiana, p. 96-129.
40. GUHL, H. 1999. The possibility of testing antiparasitical substances using the cockroach as a model. Parasitology Research 85: 945-947.
41. GUMBO, T., R. E. HOBBS, C. CARLYN, G. HALL, AND C. M. ISADA. 1999. Microsporidia infection in transplant patients. Transplantation 67: 482-484.
42. HE, Q., G. J. LEITCH, G. S. VISVESVARA, AND S. WALLACE. 1996. Effects of nifedipine, metronidazole and nitric oxide donors on spore germination and cell culture infection of the microsporidium Encephalitozoon hellum and Encephalitozoon intestinalis. Antimicrobial Agents and Chemotherapy 40: 179-185.
43. JARONSKI, S. T., 1972. Cytochemical evidence for RNA synthesis inhibition by fumagillin. Eye 8: 703-704.
44. JOHNY, S., S. KANGINAKUDRU, M. C. MURALIRANGAN, AND J. NAGARAJU. 2006. Morphological and molecular characterization of a new microsporidian isolate from Spodoptera litura. Parasitology 132: 803-814.
45. JOSTE, N. E., J. D. RICH, K. J. BUSAM, AND D. A. SCHWARTZ. 1996. Autopsy verification of Encephalitozoon intestinalis (microsporidiosis) eradication following albendazole therapy. Archives of Pathology and Laboratory Medicine 120: 199-203.
46. KAKRANIA, R, J. JOSEPH, P. K. VADDAVALLI, N. GANGOPADHYAY, AND S. SHARMA. 2006. Microsporidia keratoconjunctivitis in a corneal graft. Eye 20: 1314-1315.
47. KATIYAR, S. K., AND T. D. EDLIND. 1997. In vitro susceptibility of the AIDS associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolites, and 12 additional benzimidazole derivative. Antimicrobial Agents and Chemotherapy 41: 2729-2733.
48. KATZNELSON, H., AND C. A. JAMIESON. 1952. Control of Nosema disease of honeybees with fumagillin. Science 115: 70-71.
49. KENT, M. L. 2000. Marine netpen farming leads to infections with some unusual parasites. International Journal for Parasitology 30: 321-326.
50. KILLOUGH, J. H., G. B. MAGILL, AND R. C. SMITH. 1952. The treatment of amebiasis with fumagillin. Science 115: 71-72.
51. KOTLER, D. P., AND J. M. ORENSTEIN. 1999. Clinical syndromes associated with microsporidiosis. In The Microsporidia and microsporidiosis, M. Wittner, and L. M. Weiss (eds.). American Society for Microbiology Press, Washington, D.C., p. 258-292.
52. LACEY, E. 1988. The role of the cytoskeletal proteins tubulin in the mode of action and mechanism of drug resistance to benzimidazoles. International Journal for Parasitology 18: 885-936.
53. LECUIT, M., E. OKSENHENDLER, AND C. SARFATI. 1994. Use of albendazole for disseminated microsporidian infection in a patient with AIDS. Clinical Infectious Diseases 19: 332-333.
54. LEDER, K., N. RYAN, D. SPELMAN, AND S. M. CROWE. 1998. Microsporidial disease in HIV-infected patients: A report of 42 patients and review of the literature. Scandinavian Journal of Infectious Diseases 30: 331-338.
55. LOM, J., AND F. NILSEN. 2003. Fish microsporidia: Fine structure and phylogeny. International Journal for Parasitology 33: 107-127.
56. MARLEY, S. E., M. L. EBERHARD, F. J. STEURER, W. L. ELLIS, P. B. MCGREEVY, AND T. K. RUEBUSH. 1997. Evaluation of selected antiprotozoal drugs in the Babesia microti-hamster model. Antimicrobial Agents and Chemotherapy 41: 91-94.
57. MATUSZEK, J. V., AND D. W. WHITMAN. 2001. Captive rearing of eastern lubber grasshopper Romalea microptera. In Invertebrates in captivity conference. Sonoran Arthropod Studies Institute, Ron Rico, Arizona, p. 56-65.
58. MCCOWEN, M. C., M. E. CALLENDER, AND J. F. LAWLIS, JR. 1951. Fumagillin (H-3), a new antibiotic with amoebicidal properties. Science 113: 202-203.
59. MOLINA, J. M., M. D. M. TOURNEUR, C. SARFATI, S. CHEVRET, A. D. GOUVELLO, J. G. GOBERT, S. BALKAN, AND F. DEROUN. 2002. Fumagillin treatment of intestinal microsporidiosis. New England Journal of Medicine 346: 1963-1969.
60. RAO, S. N., B. S. NATH, AND B. SARATCHANDRA. 2005. Characterization and phylogenetic relationships among microsporidia infecting silkworm, Bombyx mori, using inter simple sequence repeat (ISSR) and small subunit rRNA (SSU-rRNA) sequence analysis. Genome 48: 355-366.
61. _, M. MUTHULAKSHMI, S. KANGINAKUDRU, AND J. NAGARAJU. 2004. Phylogenetic relationships of three new microsporidian isolates from the silkworm, Bombyx mori. Journal of Invertebrate Pathology 86: 87-95.
62. ROBINSON, H. J., H. F. PHARES, AND O. E. GRAESSLE. 1964. Studies on the antimycotic properties of thiabendazole. Journal of Investigative Dermatology 42: 479-482.
63. _, AND _. 1978. The toxicological and antifungal properties of thiabendazole. Ecotoxicology and Environmental Safety 1: 471-476.
64. ROSBERGER, D. F., O. N. SERDAREVIC, AND R. A. ERLANDSON. 1993. Successful treatment of microsporidial keratoconjunctivitis with topical fumagillin in a patient with AIDS. Cornea 12: 261-265.
65. ROSSI, R. M., C. WANKE, AND M. FEDERMAN. 1996. Microsporidian sinusitis in patients with the acquired immunodeficiency syndrome. Laryngoscope 106: 966-971.
66. SALZET, M. 2001. Vertebrate innate immunity resembles a mosaic of invertebrate immune responses. Trends in Immunology 22: 285-288.
67. SCHMID-HEMPEL, P. 2005. Evolutionary ecology of insect immune defenses. Annual Review of Entomology 50: 529-551.
68. SIDHU, A. B., D. VERDIER-PINARD, AND D. A. FIDOCK. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298: 210-213.
69. SINGH, P., AND R. F. MOORE. 1985. Handbook of insect rearing, vol. I. Elsevier, Amsterdam, The Netherlands, 499 p.
70. SKINNER-ADAMS, T. S., T. M. E. DAVIS, L. S. MANNING, AND W. A. JOHNSTON. 1997. The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro. Transactions of the Royal Society of Tropical Medicine and Hygiene 91: 580-584.
71. SLIFKO, T. R., H. V. SMITH, AND J. B. ROSE. 2000. Emerging parasite zoonoses associated with water and food. International Journal for Parasitology 30: 1379-1393.
72. SMITH, A. J., AND R. E. CLOPTON. 2003. Efficiency of oral metronidazole and potassium sorbate against two gregarine parasites, Protomagalhaensia granulose and Gregarina cubensis (Apicomlexa: Eugregarinida), infecting the death's head cockroach, Blaberus discoidalis. Comparative Parasitology 70: 96-99.
73. SOLTER, L. F., AND J. J. BECNEL. 2000. Entomopathogenic microsporidia. In Field manual of techniques for the evaluation of entomopathogens, L. Lacey, and H. Kaya (eds.). Kluwer Academic Publishers, Dordrecht, The Netherlands, p. 231-254.
74. STREET, D. A., AND M. R. MCGUIRE. 1990. Pathogenic diseases of grasshoppers. In Biology of grasshoppers, R. F. Chapman and A. Joern (eds.). Wiley, New York, New York, p. 483-516.
75. SUN, T., M. H. KAPLAN, S. TEICHBERG, G. WEISSMAN, T. SMILARI, AND C. URMACHER. 1994. Intestinal microsporidiosis: Report of five cases. Annals of Clinical and Laboratory Science 24: 521-532
76. VAN FRANKENHUYZEN, K., P. EBLING, B. MCCRON, T. LADD, D. GAUTHIER, AND C. VOSSBRINCK. 2004. Occurrence of Cystosporogenes sp. (Protozoa, Microsporidia) in a multi-species insect production facility and its elimination from a colony of the eastern spruce budworm, Choristoneura fumiferana (Clem.) (Lepidoptera: Tortricidae). Journal Invertebrate Pathology 87: 16-28.
77. WEBER, R., P. DEPLAZES, AND D. SCHWARTZ. 2000. Diagnosis and clinical aspects of human microsporidiosis. Contributions to Microbiology 6: 166-192.
78. _, P. DEPLAZES, M. FLEPP, A. MATHIS, R. BAUMANN, B. SAUER, H. KUSTER, AND R. LUTHY. 1997. Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. New England Journal of Medicine 336: 474-478.
79. WEBSTER, T. C. 1994. Fumagillin affects Nosema apis and honey bees (Hymenoptera: Apidae). Journal of Economic Entomology 87: 601-604.
80. WEISS, L. M. 2001. Microsporidia: Emerging pathogenic protests. Acta Tropica 78: 89-102.
81. WEN, L. P., Z. Y. WANG, K. L. HE, S. X. BAI, AND D. R. ZHOU. 2003. The control techniques of microsporidiosis in mass rearing of Asian corn borer. Acta Phytophylacica Sinica 30: 13-18.
82. WILKINS, J. H., N. JOSHI, T. P. MARGOLIS, V. CEVALLOS, AND C. R. DAWSON. 1994. Microsporidial keratoconjunctivitis treated with successfully with short course of fumagillin. Eye 8: 703-704.
83. WITTNER, M. 1999. Historic perspective on the microsporidia: expanding horizons. In The Microsporidia and microsporidiosis, M. Witmmer and L. M. Weiss (eds.). American Society for Microbiology Press, Washington, D.C., p. 1-6.
84. _, AND L. M. WEISS. 1999. The microsporidia and microsporidiosis. American Society for Microbiology Press, Washington, D.C., 572 p.
85. WOYKE, J. 1984. Increase in life span, unit honey productivity and honey surplus with fumagillin treatment of honeybees. Journal of Apiculture Research 23: 209-212.